Readers of DNA methylation, the MBD family as potential therapeutic targets

Acuna-Hidalgo, 2017, Ultra-sensitive sequencing identifies high prevalence of clonal hematopoiesis-associated mutations throughout adult life, American Journal of Human Genetics, 101, 50, 10.1016/j.ajhg.2017.05.013 Aguilera, 2011, c-Jun N-terminal phosphorylation antagonises recruitment of the Mbd3/NuRD repressor complex, Nature, 469, 231, 10.1038/nature09607 Alqarni, 2014, Insight into the architecture of the NuRD complex: Structure of the RbAp48-MTA1 subcomplex, The Journal of Biological Chemistry, 289, 21844, 10.1074/jbc.M114.558940 Amaya, 2013, Mi2beta-mediated silencing of the fetal gamma-globin gene in adult erythroid cells, Blood, 121, 3493, 10.1182/blood-2012-11-466227 Amir, 1999, Rett syndrome is caused by mutations in X-linked MECP2, encoding methyl-CpG-binding protein 2, Nature Genetics, 23, 185, 10.1038/13810 Ang, 2009, BRAF mutation is associated with the CpG island methylator phenotype in colorectal cancer from young patients, Cancer Letters, 273, 221, 10.1016/j.canlet.2008.08.001 Aoki, 2001, Enzymatic properties of de novo-type mouse DNA (cytosine-5) methyltransferases, Nucleic Acids Research, 29, 3506, 10.1093/nar/29.17.3506 Bakker, 2002, Methyl-CpG binding domain protein 2 represses transcription from hypermethylated pi-class glutathione S-transferase gene promoters in hepatocellular carcinoma cells, The Journal of Biological Chemistry, 277, 22573, 10.1074/jbc.M203009200 Ballestar, 2005, Methyl-CpG-binding proteins in cancer: Blaming the DNA methylation messenger, Biochemistry and Cell Biology, 83, 374, 10.1139/o05-035 Baylin, 1986, DNA methylation patterns of the calcitonin gene in human lung cancers and lymphomas, Cancer Research, 46, 2917 Baylin, 2011, A decade of exploring the cancer epigenome — Biological and translational implications, Nature Reviews. Cancer, 11, 726, 10.1038/nrc3130 Baymaz, 2014, MBD5 and MBD6 interact with the human PR-DUB complex through their methyl-CpG-binding domain, Proteomics, 14, 2179, 10.1002/pmic.201400013 Bejar, 2014, TET2 mutations predict response to hypomethylating agents in myelodysplastic syndrome patients, Blood, 124, 2705, 10.1182/blood-2014-06-582809 Bianchi, 2015, Molecular dynamics study of the recognition of dimethylated CpG sites by MBD1 protein, Journal of Chemical Information and Modeling, 55, 636, 10.1021/ci500657d Bird, 1978, Use of restriction enzymes to study eukaryotic DNA methylation: II. The symmetry of methylated sites supports semi-conservative copying of the methylation pattern, Journal of Molecular Biology, 118, 49, 10.1016/0022-2836(78)90243-7 Bird, 1986, CpG-rich islands and the function of DNA methylation, Nature, 321, 209, 10.1038/321209a0 Bird, 1978, Use of restriction enzymes to study eukaryotic DNA methylation: I. The methylation pattern in ribosomal DNA from Xenopus laevis, Journal of Molecular Biology, 118, 27, 10.1016/0022-2836(78)90242-5 Blow, 2016, The epigenomic landscape of prokaryotes, PLoS Genetics, 12, 10.1371/journal.pgen.1005854 Bochtler, 2017, DNA demethylation pathways: Additional players and regulators, BioEssays, 39, 1, 10.1002/bies.201600178 Boeckler, 2008, Targeted rescue of a destabilized mutant of p53 by an in silico screened drug, Proceedings of the National Academy of Sciences of the United States of America, 105, 10360, 10.1073/pnas.0805326105 Brackertz, 2002, Two highly related p66 proteins comprise a new family of potent transcriptional repressors interacting with MBD2 and MBD3, The Journal of Biological Chemistry, 277, 40958, 10.1074/jbc.M207467200 Brackertz, 2006, p66alpha and p66beta of the Mi-2/NuRD complex mediate MBD2 and histone interaction, Nucleic Acids Research, 34, 397, 10.1093/nar/gkj437 Brasen, 2017, Expression, purification and characterization of the human MTA2-RBBP7 complex, Biochimica et Biophysica Acta, 1865, 531, 10.1016/j.bbapap.2017.02.002 Brocks, 2017, DNMT and HDAC inhibitors induce cryptic transcription start sites encoded in long terminal repeats, Nature Genetics, 49, 1052, 10.1038/ng.3889 Bromley, 2016, An in silico algorithm for identifying stabilizing pockets in proteins: Test case, the Y220C mutant of the p53 tumor suppressor protein, Protein Engineering, Design & Selection, 29, 377, 10.1093/protein/gzw035 Burdon, 1966, Methylation of nucleic acids in Krebs II ascites tumour cells, Nature, 210, 797, 10.1038/210797a0 Buscarlet, 2017, DNMT3A and TET2 dominate clonal hematopoiesis, demonstrate benign phenotypes and different genetic predisposition, Blood, 130, 753, 10.1182/blood-2017-04-777029 Busque, 2012, Recurrent somatic TET2 mutations in normal elderly individuals with clonal hematopoiesis, Nature Genetics, 44, 1179, 10.1038/ng.2413 Busslinger, 1983, DNA methylation and the regulation of globin gene expression, Cell, 34, 197, 10.1016/0092-8674(83)90150-2 Casadesus, 2006, Epigenetic gene regulation in the bacterial world, Microbiology and Molecular Biology Reviews, 70, 830, 10.1128/MMBR.00016-06 Charache, 1983, Treatment of sickle cell anemia with 5-azacytidine results in increased fetal hemoglobin production and is associated with nonrandom hypomethylation of DNA around the gamma-delta-beta-globin gene complex, Proceedings of the National Academy of Sciences of the United States of America, 80, 4842, 10.1073/pnas.80.15.4842 Cheishvili, 2014, Synergistic effects of combined DNA methyltransferase inhibition and MBD2 depletion on breast cancer cells; MBD2 depletion blocks 5-aza-2′-deoxycytidine-triggered invasiveness, Carcinogenesis, 35, 2436, 10.1093/carcin/bgu181 Christman, 1984, DNA methylation in friend erythroleukemia cells: The effects of chemically induced differentiation and of treatment with inhibitors of DNA methylation, Current Topics in Microbiology and Immunology, 108, 49 Cimmino, 2017 Clouaire, 2010, Recruitment of MBD1 to target genes requires sequence-specific interaction of the MBD domain with methylated DNA, Nucleic Acids Research, 38, 4620, 10.1093/nar/gkq228 Constantinides, 1978, Phenotypic conversion of cultured mouse embryo cells by aza pyrimidine nucleosides, Developmental Biology, 66, 57, 10.1016/0012-1606(78)90273-7 Cooper, 2010, Methylation-mediated deamination of 5-methylcytosine appears to give rise to mutations causing human inherited disease in CpNpG trinucleotides, as well as in CpG dinucleotides, Human Genomics, 4, 406, 10.1186/1479-7364-4-6-406 Cramer, 2017, Methylation specific targeting of a chromatin remodeling complex from sponges to humans, Scientific Reports, 7, 40674, 10.1038/srep40674 Cramer, 2014, Probing the dynamic distribution of bound states for methylcytosine-binding domains on DNA, The Journal of Biological Chemistry, 289, 1294, 10.1074/jbc.M113.512236 Cui, 2017, MiR-520b inhibits the development of glioma by directly targeting MBD2, American Journal of Cancer Research, 7, 1528 Dang, 2009, Cancer-associated IDH1 mutations produce 2-hydroxyglutarate, Nature, 462, 739, 10.1038/nature08617 Davalos, 2017, The epigenomic revolution in breast cancer: From single-gene to genome-wide next-generation approaches, The American Journal of Pathology, 187, 2163, 10.1016/j.ajpath.2017.07.002 Desai, 2015, An intrinsically disordered region of methyl-CpG binding domain protein 2 (MBD2) recruits the histone deacetylase core of the NuRD complex, Nucleic Acids Research, 43, 3100, 10.1093/nar/gkv168 DeSimone, 1982, 5-Azacytidine stimulates fetal hemoglobin synthesis in anemic baboons, Proceedings of the National Academy of Sciences of the United States of America, 79, 4428, 10.1073/pnas.79.14.4428 Duncan, 1980, Mutagenic deamination of cytosine residues in DNA, Nature, 287, 560, 10.1038/287560a0 Edwards, 2017, DNA methylation and DNA methyltransferases, Epigenetics & Chromatin, 10, 23, 10.1186/s13072-017-0130-8 Fang, 2011, Breast cancer methylomes establish an epigenomic foundation for metastasis, Science Translational Medicine, 3, 75ra25, 10.1126/scitranslmed.3001875 Feinberg, 1983, Hypomethylation distinguishes genes of some human cancers from their normal counterparts, Nature, 301, 89, 10.1038/301089a0 Figueroa, 2010, Leukemic IDH1 and IDH2 mutations result in a hypermethylation phenotype, disrupt TET2 function, and impair hematopoietic differentiation, Cancer Cell, 18, 553, 10.1016/j.ccr.2010.11.015 Flavahan, 2016, Insulator dysfunction and oncogene activation in IDH mutant gliomas, Nature, 529, 110, 10.1038/nature16490 Fraga, 2003, The affinity of different MBD proteins for a specific methylated locus depends on their intrinsic binding properties, Nucleic Acids Research, 31, 1765, 10.1093/nar/gkg249 Gabel, 2015, Disruption of DNA-methylation-dependent long gene repression in Rett syndrome, Nature, 522, 89, 10.1038/nature14319 Gadalla, 2011, MeCP2 and Rett syndrome: Reversibility and potential avenues for therapy, The Biochemical Journal, 439, 1, 10.1042/BJ20110648 Gardiner-Garden, 1987, CpG islands in vertebrate genomes, Journal of Molecular Biology, 196, 261, 10.1016/0022-2836(87)90689-9 Genovese, 2014, Clonal hematopoiesis and blood-cancer risk inferred from blood DNA sequence, The New England Journal of Medicine, 371, 2477, 10.1056/NEJMoa1409405 Ghirlando, 2016, CTCF: Making the right connections, Genes & Development, 30, 881, 10.1101/gad.277863.116 Ghosh, 2008, Rett syndrome-causing mutations in human MeCP2 result in diverse structural changes that impact folding and DNA interactions, The Journal of Biological Chemistry, 283, 20523, 10.1074/jbc.M803021200 Ginder, 2015, Epigenetic regulation of fetal globin gene expression in adult erythroid cells, Translational Research, 165, 115, 10.1016/j.trsl.2014.05.002 Ginder, 1983, In vivo demethylation of chicken embryonic beta-type globin genes with 5-azacytidine, Progress in Clinical and Biological Research, 134, 501 Ginder, 1984, Activation of a chicken embryonic globin gene in adult erythroid cells by 5-azacytidine and sodium butyrate, Proceedings of the National Academy of Sciences of the United States of America, 81, 3954, 10.1073/pnas.81.13.3954 Gnanapragasam, 2011, p66Alpha-MBD2 coiled-coil interaction and recruitment of Mi-2 are critical for globin gene silencing by the MBD2-NuRD complex, Proceedings of the National Academy of Sciences of the United States of America, 108, 7487, 10.1073/pnas.1015341108 Gnyszka, 2013, DNA methyltransferase inhibitors and their emerging role in epigenetic therapy of cancer, Anticancer Research, 33, 2989 Goelz, 1985, Hypomethylation of DNA from benign and malignant human colon neoplasms, Science, 228, 187, 10.1126/science.2579435 Goncearenco, 2017, Exploring protein-protein interactions as drug targets for anti-cancer therapy with in silico workflows, Methods in Molecular Biology, 1647, 221, 10.1007/978-1-4939-7201-2_15 Gowher, 2001, Enzymatic properties of recombinant Dnmt3a DNA methyltransferase from mouse: The enzyme modifies DNA in a non-processive manner and also methylates non-CpG [correction of non-CpA] sites, Journal of Molecular Biology, 309, 1201, 10.1006/jmbi.2001.4710 Gravina, 2010, Biological rationale for the use of DNA methyltransferase inhibitors as new strategy for modulation of tumor response to chemotherapy and radiation, Molecular Cancer, 9, 305, 10.1186/1476-4598-9-305 Gros, 2012, DNA methylation inhibitors in cancer: Recent and future approaches, Biochimie, 94, 2280, 10.1016/j.biochi.2012.07.025 Gross, 2010, Cancer-associated metabolite 2-hydroxyglutarate accumulates in acute myelogenous leukemia with isocitrate dehydrogenase 1 and 2 mutations, The Journal of Experimental Medicine, 207, 339, 10.1084/jem.20092506 Guillamot, 2016, The impact of DNA methylation in hematopoietic malignancies, Trends Cancer, 2, 70, 10.1016/j.trecan.2015.12.006 Gunther, 2013, Differential roles for MBD2 and MBD3 at methylated CpG islands, active promoters and binding to exon sequences, Nucleic Acids Research, 41, 3010, 10.1093/nar/gkt035 Hahn, 2014, 5-Hydroxymethylcytosine: A stable or transient DNA modification?, Genomics, 104, 314, 10.1016/j.ygeno.2014.08.015 Hao, 2017, DNA methylation markers for diagnosis and prognosis of common cancers, Proceedings of the National Academy of Sciences of the United States of America, 114, 7414, 10.1073/pnas.1703577114 Hashimoto, 2012, Excision of 5-hydroxymethyluracil and 5-carboxylcytosine by the thymine DNA glycosylase domain: Its structural basis and implications for active DNA demethylation, Nucleic Acids Research, 40, 10203, 10.1093/nar/gks845 Hashimoto, 2012, Recognition and potential mechanisms for replication and erasure of cytosine hydroxymethylation, Nucleic Acids Research, 40, 4841, 10.1093/nar/gks155 Hashimoto, 2017, Structural basis for the versatile and methylation-dependent binding of CTCF to DNA, Molecular Cell, 66 Hashimoto, 2015, The mechanisms of generation, recognition, and erasure of DNA 5-methylcytosine and thymine oxidations, The Journal of Biological Chemistry, 290, 20723, 10.1074/jbc.R115.656884 He, 2011, Tet-mediated formation of 5-carboxylcytosine and its excision by TDG in mammalian DNA, Science, 333, 1303, 10.1126/science.1210944 Heitmann, 2003, Solution structure of the matrix attachment region-binding domain of chicken MeCP2, European Journal of Biochemistry, 270, 3263, 10.1046/j.1432-1033.2003.03714.x Hendrich, 1999, Genomic structure and chromosomal mapping of the murine and human Mbd1, Mbd2, Mbd3, and Mbd4 genes, Mammalian Genome, 10, 906, 10.1007/s003359901112 Hendrich, 1998, Identification and characterization of a family of mammalian methyl-CpG binding proteins, Molecular and Cellular Biology, 18, 6538, 10.1128/MCB.18.11.6538 Hendrich, 2001, Closely related proteins MBD2 and MBD3 play distinctive but interacting roles in mouse development, Genes & Development, 15, 710, 10.1101/gad.194101 Hendrich, 1999, The thymine glycosylase MBD4 can bind to the product of deamination at methylated CpG sites, Nature, 401, 301, 10.1038/45843 Hendrich, 2003, The methyl-CpG binding domain and the evolving role of DNA methylation in animals, Trends in Genetics, 19, 269, 10.1016/S0168-9525(03)00080-5 Ho, 2008, MeCP2 binding to DNA depends upon hydration at methyl-CpG, Molecular Cell, 29, 525, 10.1016/j.molcel.2007.12.028 Holliday, 1975, DNA modification mechanisms and gene activity during development, Science, 187, 226, 10.1126/science.1111098 Holm, 2016, An integrated genomics analysis of epigenetic subtypes in human breast tumors links DNA methylation patterns to chromatin states in normal mammary cells, Breast Cancer Research, 18, 27, 10.1186/s13058-016-0685-5 Hotchkiss, 1948, The quantitative separation of purines, pyrimidines, and nucleosides by paper chromatography, The Journal of Biological Chemistry, 175, 315, 10.1016/S0021-9258(18)57261-6 Illingworth, 2009, CpG islands--'a rough guide', FEBS Letters, 583, 1713, 10.1016/j.febslet.2009.04.012 Issa, 1997, DNA methylation changes in hematologic malignancies: Biologic and clinical implications, Leukemia, 11, S7 Itzykson, 2014, Epigenetics of myelodysplastic syndromes, Leukemia, 28, 497, 10.1038/leu.2013.343 Itzykson, 2011, Impact of TET2 mutations on response rate to azacitidine in myelodysplastic syndromes and low blast count acute myeloid leukemias, Leukemia, 25, 1147, 10.1038/leu.2011.71 Jabbari, 2004, Cytosine methylation and CpG, TpG (CpA) and TpA frequencies, Gene, 333, 143, 10.1016/j.gene.2004.02.043 Jaiswal, 2014, Age-related clonal hematopoiesis associated with adverse outcomes, The New England Journal of Medicine, 371, 2488, 10.1056/NEJMoa1408617 Jeltsch, 2006, Molecular enzymology of mammalian DNA methyltransferases, Current Topics in Microbiology and Immunology, 301, 203 Jia, 2016, Different definitions of CpG island methylator phenotype and outcomes of colorectal cancer: A systematic review, Clinical Epigenetics, 8, 25, 10.1186/s13148-016-0191-8 Jia, 2016, No association of CpG island methylator phenotype and colorectal cancer survival: Population-based study, British Journal of Cancer, 115, 1359, 10.1038/bjc.2016.361 Jiang, 2015, The epigenetic basis of diffuse large B-cell lymphoma, Seminars in Hematology, 52, 86, 10.1053/j.seminhematol.2015.01.003 Johnson, 1925, Researches on pyrimidines. C111. The discovery of 5-methyl-cytosine in tuberculinic acid, the nucleic acid of the tubercle bacillus1, Journal of the American Chemical Society, 47, 2838, 10.1021/ja01688a030 Jones, 1986, DNA methylation and cancer, Cancer Research, 46, 461 Jones, 1980, Cellular differentiation, cytidine analogs and DNA methylation, Cell, 20, 85, 10.1016/0092-8674(80)90237-8 Josse, 1961, Enzymatic synthesis of deoxyribonucleic acid. VIII. Frequencies of nearest neighbor base sequences in deoxyribonucleic acid, The Journal of Biological Chemistry, 236, 864, 10.1016/S0021-9258(18)64321-2 Jurkowska, 2016, Enzymology of mammalian DNA methyltransferases, Advances in Experimental Medicine and Biology, 945, 87, 10.1007/978-3-319-43624-1_5 Kang, 2015, Disruption of CTCF/cohesin-mediated high-order chromatin structures by DNA methylation downregulates PTGS2 expression, Oncogene, 34, 5677, 10.1038/onc.2015.17 Kelly, 2017, A CpG island methylator phenotype in acute myeloid leukemia independent of IDH mutations and associated with a favorable outcome, Leukemia, 31, 2011, 10.1038/leu.2017.12 Kim, 2017, CpG island methylator phenotype is an independent predictor of survival after curative resection for colorectal cancer: A prospective cohort study, Journal of Gastroenterology and Hepatology, 32, 1469, 10.1111/jgh.13734 Kinde, 2015, Reading the unique DNA methylation landscape of the brain: Non-CpG methylation, hydroxymethylation, and MeCP2, Proceedings of the National Academy of Sciences of the United States of America, 112, 6800, 10.1073/pnas.1411269112 Kirby, 2017, Genome-wide DNA methylation measurements in prostate tissues uncovers novel prostate cancer diagnostic biomarkers and transcription factor binding patterns, BMC Cancer, 17, 273, 10.1186/s12885-017-3252-2 Kloet, 2015, Towards elucidating the stability, dynamics and architecture of the nucleosome remodeling and deacetylase complex by using quantitative interaction proteomics, The FEBS Journal, 282, 1774, 10.1111/febs.12972 Klose, 2005, DNA binding selectivity of MeCP2 due to a requirement for A/T sequences adjacent to methyl-CpG, Molecular Cell, 19, 667, 10.1016/j.molcel.2005.07.021 Kransdorf, 2006, MBD2 is a critical component of a methyl cytosine-binding protein complex isolated from primary erythroid cells, Blood, 108, 2836, 10.1182/blood-2006-04-016394 Laget, 2010, The human proteins MBD5 and MBD6 associate with heterochromatin but they do not bind methylated DNA, PLoS One, 5, 10.1371/journal.pone.0011982 Lagger, 2017, MeCP2 recognizes cytosine methylated tri-nucleotide and di-nucleotide sequences to tune transcription in the mammalian brain, PLoS Genetics, 13, 10.1371/journal.pgen.1006793 Le Guezennec, 2006, MBD2/NuRD and MBD3/NuRD, two distinct complexes with different biochemical and functional properties, Molecular and Cellular Biology, 26, 843, 10.1128/MCB.26.3.843-851.2006 Lewis, 1992, Purification, sequence, and cellular localization of a novel chromosomal protein that binds to methylated DNA, Cell, 69, 905, 10.1016/0092-8674(92)90610-O Ley, 1982, 5-Azacytidine selectively increases gamma-globin synthesis in a patient with beta+ thalassemia, The New England Journal of Medicine, 307, 1469, 10.1056/NEJM198212093072401 Lin, 2003, Methyl-CpG-binding domain protein-2 mediates transcriptional repression associated with hypermethylated GSTP1 CpG islands in MCF-7 breast cancer cells, Cancer Research, 63, 498 Liu, 2016, Editing DNA methylation in the mammalian genome, Cell, 167 Lopez-Serra, 2006, A profile of methyl-CpG binding domain protein occupancy of hypermethylated promoter CpG islands of tumor suppressor genes in human cancer, Cancer Research, 66, 8342, 10.1158/0008-5472.CAN-06-1932 Lopez-Serra, 2008, Unmasking of epigenetically silenced candidate tumor suppressor genes by removal of methyl-CpG-binding domain proteins, Oncogene, 27, 3556, 10.1038/sj.onc.1211022 Lopez-Serra, 2008, Proteins that bind methylated DNA and human cancer: Reading the wrong words, British Journal of Cancer, 98, 1881, 10.1038/sj.bjc.6604374 Loughran, 2017, Mbd3/NuRD controls lymphoid cell fate and inhibits tumorigenesis by repressing a B cell transcriptional program, The Journal of Experimental Medicine, 214, 3085, 10.1084/jem.20161827 Low, 2016, CHD4 is a peripheral component of the nucleosome remodeling and deacetylase complex, The Journal of Biological Chemistry, 291, 15853, 10.1074/jbc.M115.707018 Lu, 2016, Loss and gain of MeCP2 cause similar hippocampal circuit dysfunction that is rescued by deep brain stimulation in a Rett syndrome mouse model, Neuron, 91, 739, 10.1016/j.neuron.2016.07.018 Lyst, 2015, Rett syndrome: A complex disorder with simple roots, Nature Reviews. Genetics, 16, 261, 10.1038/nrg3897 Magdinier, 2001, Selective association of the methyl-CpG binding protein MBD2 with the silent p14/p16 locus in human neoplasia, Proceedings of the National Academy of Sciences of the United States of America, 98, 4990, 10.1073/pnas.101617298 Manvilla, 2012, Crystal structure of human methyl-binding domain IV glycosylase bound to abasic DNA, Journal of Molecular Biology, 420, 164, 10.1016/j.jmb.2012.04.028 Massie, 2017, The importance of DNA methylation in prostate cancer development, The Journal of Steroid Biochemistry and Molecular Biology, 166, 1, 10.1016/j.jsbmb.2016.04.009 Mayer, 2000, Demethylation of the zygotic paternal genome, Nature, 403, 501, 10.1038/35000656 McGhee, 1979, Specific DNA methylation sites in the vicinity of the chicken beta-globin genes, Nature, 280, 419, 10.1038/280419a0 Meehan, 1989, Identification of a mammalian protein that binds specifically to DNA containing methylated CpGs, Cell, 58, 499, 10.1016/0092-8674(89)90430-3 Menafra, 2014, Genome-wide binding of MBD2 reveals strong preference for highly methylated loci, PLoS One, 9, 10.1371/journal.pone.0099603 Menafra, 2014, MBD2 and MBD3: Elusive functions and mechanisms, Frontiers in Genetics, 5, 428, 10.3389/fgene.2014.00428 Meszaros, 2007, Molecular principles of the interactions of disordered proteins, Journal of Molecular Biology, 372, 549, 10.1016/j.jmb.2007.07.004 Mian, 2011, Methyl-binding domain protein 2-dependent proliferation and survival of breast cancer cells, Molecular Cancer Research, 9, 1152, 10.1158/1541-7786.MCR-11-0252 Micevic, 2017, Aberrant DNA methylation in melanoma: Biomarker and therapeutic opportunities, Clinical Epigenetics, 9, 34, 10.1186/s13148-017-0332-8 Millard, 2016, The structure of the core NuRD repression complex provides insights into its interaction with chromatin, eLife, 5, 10.7554/eLife.13941 Millard, 2013, Class I HDACs share a common mechanism of regulation by inositol phosphates, Molecular Cell, 51, 57, 10.1016/j.molcel.2013.05.020 Morera, 2012, Biochemical and structural characterization of the glycosylase domain of MBD4 bound to thymine and 5-hydroxymethyuracil-containing DNA, Nucleic Acids Research, 40, 9917, 10.1093/nar/gks714 Murzina, 2008, Structural basis for the recognition of histone H4 by the histone-chaperone RbAp46, Structure, 16, 1077, 10.1016/j.str.2008.05.006 Nan, 1993, Dissection of the methyl-CpG binding domain from the chromosomal protein MeCP2, Nucleic Acids Research, 21, 4886, 10.1093/nar/21.21.4886 Ng, 2000, Active repression of methylated genes by the chromosomal protein MBD1, Molecular and Cellular Biology, 20, 1394, 10.1128/MCB.20.4.1394-1406.2000 Ng, 1999, MBD2 is a transcriptional repressor belonging to the MeCP1 histone deacetylase complex, Nature Genetics, 23, 58, 10.1038/12659 Noushmehr, 2010, Identification of a CpG island methylator phenotype that defines a distinct subgroup of glioma, Cancer Cell, 17, 510, 10.1016/j.ccr.2010.03.017 Ogino, 2007, Evaluation of markers for CpG island methylator phenotype (CIMP) in colorectal cancer by a large population-based sample, The Journal of Molecular Diagnostics, 9, 305, 10.2353/jmoldx.2007.060170 Ohki, 2001, Solution structure of the methyl-CpG binding domain of human MBD1 in complex with methylated DNA, Cell, 105, 487, 10.1016/S0092-8674(01)00324-5 Ohki, 1999, Solution structure of the methyl-CpG-binding domain of the methylation-dependent transcriptional repressor MBD1, The EMBO Journal, 18, 6653, 10.1093/emboj/18.23.6653 Otani, 2013, Structural basis of the versatile DNA recognition ability of the methyl-CpG binding domain of methyl-CpG binding domain protein 4, The Journal of Biological Chemistry, 288, 6351, 10.1074/jbc.M112.431098 Pan, 2017, CpG and methylation-dependent DNA binding and dynamics of the methylcytosine binding domain 2 protein at the single-molecule level, Nucleic Acids Research, 45, 9164, 10.1093/nar/gkx548 Pechalrieu, 2017, DNA methyltransferase inhibitors in cancer: From pharmacology to translational studies, Biochemical Pharmacology, 129, 1, 10.1016/j.bcp.2016.12.004 Petronzelli, 2000, Investigation of the substrate spectrum of the human mismatch-specific DNA N-glycosylase MED1 (MBD4): Fundamental role of the catalytic domain, Journal of Cellular Physiology, 185, 473, 10.1002/1097-4652(200012)185:3<473::AID-JCP19>3.0.CO;2-# Petronzelli, 2000, Biphasic kinetics of the human DNA repair protein MED1 (MBD4), a mismatch-specific DNA N-glycosylase, The Journal of Biological Chemistry, 275, 32422, 10.1074/jbc.M004535200 Pinney, 2014, Mammalian non-CpG methylation: Stem cells and beyond, Biology (Basel), 3, 739 Plimack, 2007, Decitabine and its role in the treatment of hematopoietic malignancies, Leukemia & Lymphoma, 48, 1472, 10.1080/10428190701471981 van der Ploeg, 1980, DNA methylation in the human γδβ-globin locus in erythroid and nonerythroid tissues, Cell, 19, 947, 10.1016/0092-8674(80)90086-0 Rais, 2013, Deterministic direct reprogramming of somatic cells to pluripotency, Nature, 502, 65, 10.1038/nature12587 Ramsahoye, 2000, Non-CpG methylation is prevalent in embryonic stem cells and may be mediated by DNA methyltransferase 3a, Proceedings of the National Academy of Sciences of the United States of America, 97, 5237, 10.1073/pnas.97.10.5237 Rauch, 2005, Towards an understanding of DNA recognition by the methyl-CpG binding domain 1, Journal of Biomolecular Structure & Dynamics, 22, 695, 10.1080/07391102.2005.10507036 Razin, 1980, DNA methylation and gene function, Science, 210, 604, 10.1126/science.6254144 Riggs, 1975, X inactivation, differentiation, and DNA methylation, Cytogenetics and Cell Genetics, 14, 9, 10.1159/000130315 Rupon, 2006, Methyl binding domain protein 2 mediates gamma-globin gene silencing in adult human betaYAC transgenic mice, Proceedings of the National Academy of Sciences of the United States of America, 103, 6617, 10.1073/pnas.0509322103 Sansom, 2003, Deficiency of Mbd2 suppresses intestinal tumorigenesis, Nature Genetics, 34, 145, 10.1038/ng1155 dos Santos, 2014, MBD3/NuRD facilitates induction of pluripotency in a context-dependent manner, Cell Stem Cell, 15, 102, 10.1016/j.stem.2014.04.019 Saunthararajah, 2004, Clinical studies with fetal hemoglobin-enhancing agents in sickle cell disease, Seminars in Hematology, 41, 11, 10.1053/j.seminhematol.2004.08.003 Scarsdale, 2011, Solution structure and dynamic analysis of chicken MBD2 methyl binding domain bound to a target-methylated DNA sequence, Nucleic Acids Research, 39, 6741, 10.1093/nar/gkr262 Schmidberger, 2016, The MTA1 subunit of the nucleosome remodeling and deacetylase complex can recruit two copies of RBBP4/7, Protein Science, 25, 1472, 10.1002/pro.2943 Schomacher, 2017, DNA repair and erasure of 5-methylcytosine in vertebrates, BioEssays, 39, 10.1002/bies.201600218 Schuh, 2017, Azacitidine in adult patients with acute myeloid leukemia, Critical Reviews in Oncology/Hematology, 116, 159, 10.1016/j.critrevonc.2017.05.010 Scott, 2016, Azacitidine: A review in myelodysplastic syndromes and acute myeloid Leukaemia, Drugs, 76, 889, 10.1007/s40265-016-0585-0 Shen, 1980, Tissue-specific DNA methylation in a cluster of rabbit beta-like globin genes, Proceedings of the National Academy of Sciences of the United States of America, 77, 6634, 10.1073/pnas.77.11.6634 Shih, 2017, Combination targeted therapy to disrupt aberrant oncogenic signaling and reverse epigenetic dysfunction in IDH2- and TET2-mutant acute myeloid leukemia, Cancer Discovery, 7, 494, 10.1158/2159-8290.CD-16-1049 Shimbo, 2013, MBD3 localizes at promoters, gene bodies and enhancers of active genes, PLoS Genetics, 9, 10.1371/journal.pgen.1004028 Singal, 2001, Cytosine methylation represses glutathione S-transferase P1 (GSTP1) gene expression in human prostate cancer cells, Cancer Research, 61, 4820 Singh, 2013, DNA methyltransferase-1 inhibitors as epigenetic therapy for cancer, Current Cancer Drug Targets, 13, 379, 10.2174/15680096113139990077 Smits, 2013, Stoichiometry of chromatin-associated protein complexes revealed by label-free quantitative mass spectrometry-based proteomics, Nucleic Acids Research, 41, 10.1093/nar/gks941 Song, 2008, Structural basis of histone H4 recognition by p55, Genes & Development, 22, 1313, 10.1101/gad.1653308 Spencer, 2017, CpG Island hypermethylation mediated by DNMT3A is a consequence of AML progression, Cell, 168 Sperlazza, 2017, Structural basis of MeCP2 distribution on non-CpG methylated and hydroxymethylated DNA, Journal of Molecular Biology, 429, 1581, 10.1016/j.jmb.2017.04.009 Sperlazza, 2015, Depletion of the chromatin remodeler CHD4 sensitizes AML blasts to genotoxic agents and reduces tumor formation, Blood, 126, 1462, 10.1182/blood-2015-03-631606 Spruijt, 2010, CDK2AP1/DOC-1 is a bona fide subunit of the Mi-2/NuRD complex, Molecular BioSystems, 6, 1700, 10.1039/c004108d Steensma, 2015, Clonal hematopoiesis of indeterminate potential and its distinction from myelodysplastic syndromes, Blood, 126, 9, 10.1182/blood-2015-03-631747 Stefansson, 2015, A DNA methylation-based definition of biologically distinct breast cancer subtypes, Molecular Oncology, 9, 555, 10.1016/j.molonc.2014.10.012 Suzuki, 2008, DNA methylation landscapes: Provocative insights from epigenomics, Nature Reviews. Genetics, 9, 465, 10.1038/nrg2341 Swartz, 1962, Enzymatic synthesis of deoxyribonucleic acid. XI. Further studies on nearest neighbor base sequences in deoxyribonucleic acids, The Journal of Biological Chemistry, 237, 1961, 10.1016/S0021-9258(19)73967-2 Tahiliani, 2009, Conversion of 5-methylcytosine to 5-hydroxymethylcytosine in mammalian DNA by MLL partner TET1, Science, 324, 930, 10.1126/science.1170116 Taylor, 1979, Multiple new phenotypes induced in 10T1/2 and 3T3 cells treated with 5-azacytidine, Cell, 17, 771, 10.1016/0092-8674(79)90317-9 Teif, 2014, Nucleosome repositioning links DNA (de)methylation and differential CTCF binding during stem cell development, Genome Research, 24, 1285, 10.1101/gr.164418.113 Tirado-Magallanes, 2017, Whole genome DNA methylation: Beyond genes silencing, Oncotarget, 8, 5629, 10.18632/oncotarget.13562 Toyota, 1999, CpG island methylator phenotype in colorectal cancer, Proceedings of the National Academy of Sciences of the United States of America, 96, 8681, 10.1073/pnas.96.15.8681 Toyota, 2005, Epigenetic changes in solid and hematopoietic tumors, Seminars in Oncology, 32, 521, 10.1053/j.seminoncol.2005.07.003 Turcan, 2012, IDH1 mutation is sufficient to establish the glioma hypermethylator phenotype, Nature, 483, 479, 10.1038/nature10866 Uversky, 2016, Dancing protein clouds: The strange biology and chaotic physics of intrinsically disordered proteins, The Journal of Biological Chemistry, 291, 6681, 10.1074/jbc.R115.685859 Vela, 2015, Bcl-2 family of proteins as drug targets for cancer chemotherapy: The long way of BH3 mimetics from bench to bedside, Current Opinion in Pharmacology, 23, 74, 10.1016/j.coph.2015.05.014 Vermeulen, 2008, High confidence determination of specific protein-protein interactions using quantitative mass spectrometry, Current Opinion in Biotechnology, 19, 331, 10.1016/j.copbio.2008.06.001 Wade, 1998, A multiple subunit Mi-2 histone deacetylase from Xenopus laevis cofractionates with an associated Snf2 superfamily ATPase, Current Biology, 8, 843, 10.1016/S0960-9822(98)70328-8 Wakefield, 1999, The solution structure of the domain from MeCP2 that binds to methylated DNA, Journal of Molecular Biology, 291, 1055, 10.1006/jmbi.1999.3023 Walavalkar, 2014, Solution structure and intramolecular exchange of methyl-cytosine binding domain protein 4 (MBD4) on DNA suggests a mechanism to scan for mCpG/TpG mismatches, Nucleic Acids Research, 42, 11218, 10.1093/nar/gku782 Walavalkar, 2013, Unique features of the anti-parallel, heterodimeric coiled-coil interaction between methyl-cytosine binding domain 2 (MBD2) homologues and GATA zinc finger domain containing 2A (GATAD2A/p66alpha), The Journal of Biological Chemistry, 288, 3419, 10.1074/jbc.M112.431346 Watson, 2012, Structure of HDAC3 bound to co-repressor and inositol tetraphosphate, Nature, 481, 335, 10.1038/nature10728 Wells, 2007, Reaching for high-hanging fruit in drug discovery at protein-protein interfaces, Nature, 450, 1001, 10.1038/nature06526 Wood, 2016, Tagging methyl-CpG-binding domain proteins reveals different spatiotemporal expression and supports distinct functions, Epigenomics, 8, 455, 10.2217/epi-2015-0004 Wyatt, 1950, Occurrence of 5-methyl-cytosine in nucleic acids, Nature, 166, 237, 10.1038/166237b0 Wyatt, 1951, Recognition and estimation of 5-methylcytosine in nucleic acids, The Biochemical Journal, 48, 581, 10.1042/bj0480581 Wyhs, 2014, Time-resolved fluorescence resonance energy transfer assay for discovery of small-molecule inhibitors of methyl-CpG binding domain protein 2, Journal of Biomolecular Screening, 19, 1060, 10.1177/1087057114526433 Xia, 2017, CHD4 has oncogenic functions in initiating and maintaining epigenetic suppression of multiple tumor suppressor genes, Cancer Cell, 31 Xu, 2011, Oncometabolite 2-hydroxyglutarate is a competitive inhibitor of alpha-ketoglutarate-dependent dioxygenases, Cancer Cell, 19, 17, 10.1016/j.ccr.2010.12.014 Yang, 2015, DNMT3A in haematological malignancies, Nature Reviews. Cancer, 15, 152, 10.1038/nrc3895 Zemach, 2010, Genome-wide evolutionary analysis of eukaryotic DNA methylation, Science, 328, 916, 10.1126/science.1186366 Zemach, 2010, Evolution of eukaryotic DNA methylation and the pursuit of safer sex, Current Biology, 20, R780, 10.1016/j.cub.2010.07.007 Zhang, 2016, The nucleosome remodeling and deacetylase complex NuRD is built from preformed catalytically active sub-modules, Journal of Molecular Biology, 428, 2931, 10.1016/j.jmb.2016.04.025 Zhang, 1999, Analysis of the NuRD subunits reveals a histone deacetylase core complex and a connection with DNA methylation, Genes & Development, 13, 1924, 10.1101/gad.13.15.1924 Zhao, 2009, Glioma-derived mutations in IDH1 dominantly inhibit IDH1 catalytic activity and induce HIF-1alpha, Science, 324, 261, 10.1126/science.1170944 Zhu, 2011, Overexpression of MBD2 in glioblastoma maintains epigenetic silencing and inhibits the antiangiogenic function of the tumor suppressor gene BAI1, Cancer Research, 71, 5859, 10.1158/0008-5472.CAN-11-1157 Zink, 2017, Clonal hematopoiesis, with and without candidate driver mutations, is common in the elderly, Blood, 130, 742, 10.1182/blood-2017-02-769869